Proxy Votes Now

Home › Funds › Morgan Stanley › Vitality Portfolio

Vitality Portfolio (MSVDX) proxy voting record 2025-2026

Fund family: Morgan Stanley · Filed by MORGAN STANLEY INSTITUTIONAL FUND INC (CIK 836487) · SEC series S000074797

Share classes and tickers: MSVDX (C000233002), MSVEX (C000233003), MSVMX (C000233004), MSVOX (C000233005)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 268 with, 6 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Morgan Stanley as a whole

The same two figures as Morgan Stanley’s manager page (139,958 ballot items across 61 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsMorgan StanleyItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)96.8%25086.0%111,214
Backed environmental and social shareholder proposals at US companiesn/a127.9%1,130

Where this fund voted differently from most Morgan Stanley funds

Each ballot item this fund voted is set against the votes of the other Morgan Stanley funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Morgan Stanley funds on 4 items (2.8% of the 143 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Morgan Stanley fundsMgmtResult
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaForWITHHOLD — 3 of 3 Morgan Stanley fundsForElected, 75.5% support
Doximity, Inc.2025-08-28To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Jeffrey TangneyForWITHHOLD — 3 of 3 Morgan Stanley fundsForElected, 97.0% support
Doximity, Inc.2025-08-28To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Kira WamplerForWITHHOLD — 3 of 3 Morgan Stanley fundsForElected, 91.7% support
Doximity, Inc.2025-08-28To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers for the fiscal year ended March 31, 2025.ForAGAINST — 3 of 4 Morgan Stanley fundsForPassed (calculated), 96.4% support

Download all 4 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 86.5% of this fund’s 274 such votes could be given a sector; the other 37 (13.5%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care20562.9%
Industrials1800.0%
Technology1400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1660
Audit-related310
Say-on-Pay310
Corporate Governance205
Capital Structure120
Compensation100
Extraordinary Transactions50
Shareholder Rights and Defenses30
Other Social Issues11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$259,473102
argenx SEMay 6, 2026$223,473120
argenx SENovember 18, 2025$223,47310
10x Genomics, Inc.June 4, 2026$209,01750
Thermo Fisher Scientific Inc.May 20, 2026$128,669130
Guardant Health, Inc.June 17, 2026$116,52050
Ceribell, Inc.June 2, 2026$103,43430
Enliven Therapeutics, Inc.June 9, 2026$101,24060

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalForAgainst
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 4, 2026West Pharmaceutical Services, Inc.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalAgainstFor
May 20, 2026Zoetis Inc.Shareholder proposal to permit shareholder action by written consent. Shareholder proposalForAgainst

Search this fund’s votes by company

279 ballot items at 33 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Vitality Portfolio (MSVDX) voted at 33 shareholder meetings of 32 companies, on 279 ballot items in all. Where management made a recommendation, the fund followed it on 97.8% of the items and voted against it 6 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 6 shareholder proposals. It voted FOR the board's own proposals more often than Morgan Stanley's funds as a whole (96.8% against 86.0%). It voted differently from most Morgan Stanley funds on 4 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Morgan Stanley’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.